Northwest Biotherapeutics NWBO Cash Flow Statement (2009-2026)

OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Northwest Biotherapeutics Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Northwest Biotherapeutics reported cash from operations of -$7.17M and free cash flow of -$7.37M for the quarter ended Jun 2026, down 7.2% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
45.52M133.32M-14.21M-29.67M-32.85M-28.30M-10.65M-14.45M-23.52M-13.98M-18.31M-17.87M-19.37M-28.22M-19.34M-15.38M-26.83M1.39M-3.07M-9.22M
Depreciation and DepletionDep. & Depletion
0.10M0.50M0.30M0.40M0.30M0.40M0.40M0.40M0.40M0.50M0.40M0.50M0.60M0.50M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.36M0.58M0.81M0.70M0.60M0.66M0.55M0.72M0.73M0.37M0.58M0.49M0.55M0.86M0.33M0.53M0.41M0.61M0.28M0.13M
Depreciation & Amortization (CF)Dep. & Amort.
0.10M0.08M0.10M0.52M0.31M0.32M0.34M0.35M0.42M0.42M0.43M0.43M0.45M0.44M0.43M0.45M0.45M0.73M0.77M0.77M
Share-based CompensationStock Comp.
1.26M0.87M0.62M5.76M3.36M2.56M0.93M0.28M1.62M1.58M1.16M1.15M0.69M0.45M0.39M0.36M0.27M0.19M0.29M0.18M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
58.47M145.81M0.54M-4.25M-12.17M-9.94M3.88M0.11M-0.11M-0.23M0.12M2.41M-1.59M-0.58M1.28M0.72M-3.33M1.18M9.42M
Other non-cash itemsOther Non-Cash
0.31M0.35M-0.41M0.11M0.46M2.35M1.48M0.47M-3.17M9.87M4.02M0.67M9.91M3.68M11.04M7.68M6.60M25.82M12.50M8.61M
Non-cash ItemsNon-Cash Items
-56.38M-143.87M0.64M11.41M16.96M16.04M-0.53M1.69M9.46M2.04M2.63M0.84M7.34M5.95M3.55M3.82M10.29M-15.22M-7.55M-2.99M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
0.80M1.17M-0.69M2.75M0.07M1.23M-0.34M-0.06M-1.84M-2.24M-0.81M-0.25M0.56M1.41M2.02M1.54M1.83M0.55M-0.36M
Change in Accrued ExpensesChange Accrued Exp.
0.93M-2.27M0.80M0.74M-0.28M2.24M0.98M1.23M0.45M-2.61M4.53M0.66M3.34M0.40M4.38M3.16M1.32M-1.10M0.89M2.72M
Change in Other Operating AssetsOther Assets Change
-2.14M-0.38M-0.48M0.11M0.05M0.10M0.73M-0.03M-1.48M0.30M0.49M-0.38M0.12M-0.32M0.00M-0.11M0.49M0.45M2.27M-2.43M
Change in Other Operating LiabilitiesOther Liabilities Change
0.78M1.20M-0.66M2.78M0.11M1.26M-0.30M-0.02M-1.80M-2.11M-0.77M-0.21M0.58M1.37M2.00M1.60M1.82M0.61M-0.50M-0.11M
Other Working Capital ChangesOther WC Changes
-0.27M-0.29M0.09M-0.04M-0.05M0.70M1.01M-0.75M-0.20M0.11M0.50M-0.45M0.19M-0.20M0.17M-0.08M0.68M-0.75M0.03M0.04M
Cash from OperationsCash from Ops.
-7.01M-11.25M-12.97M-14.84M-16.12M-8.85M-11.24M-11.52M-13.92M-16.96M-12.41M-16.20M-8.23M-20.18M-9.42M-6.69M-13.89M-14.76M-12.51M-7.17M
Investing Activities
Capital ExpendituresCapex
2.69M1.55M0.06M0.41M0.28M2.16M1.33M1.25M0.44M0.42M0.24M0.52M0.18M0.08M0.09M0.30M0.20M0.91M0.13M0.20M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-2.69M-1.55M-0.06M-0.41M-0.28M-2.16M-1.33M-1.25M-0.44M-0.42M-0.24M-0.52M-0.18M-0.08M-0.09M-0.30M-0.20M-0.91M-0.13M-0.20M
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Sale and Maturity of InvestmentsInvestments Sold
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-2.69M-1.55M-0.06M-0.41M-0.28M-2.16M-1.33M-1.25M-0.44M-0.42M-0.24M-0.52M-0.18M-0.08M-0.09M-0.30M-0.51M-0.91M-0.13M-0.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
2.05M15.32M0.60M5.00M10.00M1.15M11.55M10.64M7.10M10.00M4.82M12.10M7.20M-0.77M-1.61M11.57M7.47M7.93M
Long-Term Debt RepaymentsLT Debt Repayment
1.17M3.83M4.01M1.29M0.10M0.10M0.10M0.11M0.00M0.18M0.80M0.38M0.61M0.18M0.48M0.50M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.89M11.50M-3.41M-1.29M4.90M-0.10M9.90M1.04M11.55M10.47M7.10M10.00M4.01M11.72M6.59M-0.96M-2.09M11.57M6.97M7.93M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.89M11.50M-3.41M-1.29M4.90M-0.10M9.90M1.04M11.55M10.47M7.10M10.00M4.01M11.72M6.59M-0.96M-2.09M11.57M6.97M7.93M
Change in Capital Stock
Common Stock IssuedStock Issued
8.04M11.95M7.33M11.70M0.43M1.12M0.25M1.32M0.03M0.12M1.31M3.08M7.14M4.22M5.14M7.33M4.86M2.02M2.91M0.12M
Net Shares Issued and RepurchasedNet Shares Issued
8.04M11.95M7.33M11.70M0.43M1.12M0.25M1.32M0.03M0.12M1.31M3.08M7.14M4.22M5.14M7.33M4.86M2.02M2.91M0.12M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
1.43M2.62M0.95M2.97M12.38M2.53M6.20M4.99M0.37M0.87M0.89M0.35M0.69M0.23M2.09M
Net Equity Issued and RepurchasedNet Equity Issued
8.04M11.95M7.33M11.70M0.43M2.55M2.87M2.26M3.01M12.50M3.84M9.28M12.13M4.59M6.01M8.21M5.22M2.71M3.13M2.20M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
Dividends Paid - Common and PreferredDiv Paid (Total)
Other financing activities (as filed)
-0.52M0.05M3.91M0.40M0.40M0.05M0.20M-0.67M0.67M
Cash from Financing ActivitiesCash from Financing
8.92M23.67M3.92M10.41M16.29M11.35M12.58M8.64M17.12M14.42M12.09M17.14M11.62M15.94M11.73M12.45M11.56M13.59M9.21M7.37M
Additional items
Exchange Rate EffectFX Effect
0.86M0.46M0.90M2.71M4.70M-2.80M-0.78M-0.64M1.91M-1.01M0.91M-0.02M-3.15M3.55M-1.62M-3.92M3.09M0.56M2.18M-1.20M
Change in Cash
0.08M11.33M-8.21M-2.13M4.59M-2.46M-0.77M-4.77M4.67M-3.97M0.35M0.40M0.06M-0.76M0.60M1.54M0.24M-1.52M-1.25M-1.19M
Beginning Cash Balance
Ending Cash Balance
3.84M15.17M6.96M4.83M9.43M6.97M6.19M1.42M6.10M2.13M2.48M2.88M2.94M2.18M2.78M4.32M4.56M3.04M1.79M0.60M
Free Cash FlowFCF
-9.70M-12.80M-13.03M-15.25M-16.39M-11.01M-12.57M-12.77M-14.36M-17.38M-12.65M-16.72M-8.41M-20.26M-9.51M-6.99M-14.10M-15.67M-12.64M-7.37M
Net Cash FlowNCF
-0.78M10.87M-9.11M-4.84M-0.11M0.34M0.01M-4.13M2.77M-2.96M-0.56M0.42M3.21M-4.32M2.22M5.46M-2.85M-2.08M-3.43M0.01M
Interest Paid
0.33M1.22M0.70M0.17M0.04M0.03M0.03M0.11M0.09M0.14M0.16M0.04M

Northwest Biotherapeutics Cash Flow Statement API

Pull Northwest Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NWBO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY